Literature DB >> 15293324

Effect of the difference of bone turnover on peri-titanium implant osteogenesis in ovariectomized rats.

Akira Okamura1, Yasunori Ayukawa, Shinji Iyama, Kiyoshi Koyano.   

Abstract

High and low bone turnover situations, both of which are typically observed as postmenopausal and senile osteoporosis, were created by ovariectomy (OVX), and then an investigation of whether or not the difference of bone turnover affected peri-titanium (Ti) implant osteogenesis in rats was conducted. Female rats were divided into four groups. The experimental and control groups underwent OVX or sham operations at 15 or 27 weeks of age, as high or low bone turnover groups, respectively. Ti implants were inserted into the tibiae at 30 weeks, then fluorochromes were injected 10 or 20 days after the implantation for histometry. The implants were retained for 30 days and then ground sections were prepared. Afterward, the cortical bone growth rate, bone contact ratio (BCR) of the implant in both the cortical bone area and medullary canal area, and the average trabecular bone thickness around the implant were evaluated. Biochemical markers of bone turnover were also measured. Biochemical measurements indicated both increasing osteocalcin production in OVX rats and decreasing tartrate-resistant acid phosphatase activity in the low-turnover group. Histometrical measurements showed decreasing cortical growth and low BCR in the medullary canal of the low-turnover group. The high-turnover group demonstrated BCR as high as that of the control group. There was no significant difference in the average trabecular bone thickness around the implant among the groups. As a result, two types of osteoporotic situations were confirmed and it was shown that the difference of bone turnover was clearly due to the diverse osteogenesis around the Ti implant. Copyright 2004 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15293324     DOI: 10.1002/jbm.a.30110

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  6 in total

1.  Osteoblasts exhibit a more differentiated phenotype and increased bone morphogenetic protein production on titanium alloy substrates than on poly-ether-ether-ketone.

Authors:  Rene Olivares-Navarrete; Rolando A Gittens; Jennifer M Schneider; Sharon L Hyzy; David A Haithcock; Peter F Ullrich; Zvi Schwartz; Barbara D Boyan
Journal:  Spine J       Date:  2012-03-15       Impact factor: 4.166

2.  CHANGES OF WNT/B-CATENIN SIGNALING AND DIFFERENTIATION POTENTIAL OF BONE MARROW MESENCHYMAL STEM CELLS IN PROCESS OF BONE LOSS IN OVARIECTOMIZED RATS.

Authors:  W Ren; D Gan; G Tan; H Xue; N Li; Z Xu
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Apr-Jun       Impact factor: 0.877

3.  Lithium chloride enhances bone regeneration and implant osseointegration in osteoporotic conditions.

Authors:  Yifan Jin; Lihua Xu; Xiaohui Hu; Shixian Liao; Janak L Pathak; Jinsong Liu
Journal:  J Bone Miner Metab       Date:  2016-10-06       Impact factor: 2.626

4.  Sex dependent regulation of osteoblast response to implant surface properties by systemic hormones.

Authors:  Rene Olivares-Navarrete; Sharon L Hyzy; Reyhaan A Chaudhri; Ge Zhao; Barbara D Boyan; Zvi Schwartz
Journal:  Biol Sex Differ       Date:  2010-11-04       Impact factor: 5.027

5.  UV-Photofunctionalization of Titanium Promotes Mechanical Anchorage in A Rat Osteoporosis Model.

Authors:  Takashi Taniyama; Juri Saruta; Naser Mohammadzadeh Rezaei; Kourosh Nakhaei; Amirreza Ghassemi; Makoto Hirota; Takahisa Okubo; Takayuki Ikeda; Yoshihiko Sugita; Masakazu Hasegawa; Takahiro Ogawa
Journal:  Int J Mol Sci       Date:  2020-02-12       Impact factor: 5.923

6.  Improved anchorage of Ti6Al4V orthopaedic bone implants through oligonucleotide mediated immobilization of BMP-2 in osteoporotic rats.

Authors:  Julia V Wölfle; Jörg Fiedler; Lutz Dürselen; Judith Reichert; Dieter Scharnweber; Anne Förster; Bernd Schwenzer; Heiko Reichel; Anita Ignatius; Rolf E Brenner
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.